The second Russian vaccine against COVID-19 entered the civil circulation

As part of the third stage of testing, EpiVacCoron will receive three thousand volunteers in five regions of Russia.


According to RIA Novosti, the head of Rospotrebnadzor Anna Popova said that the vaccine “EpiVacCorona” from the center “Vector” entered the civil circulation.

“Everyone who is vaccinated is given special reminders to draw attention to the rules of conduct after the procedure”, – she added.

Popova said that as part of the third stage of testing, “EpiVacCorona” receive three thousand volunteers in five regions of Russia.

“Post-registration and clinical trials are being carried out at the third stage of the vaccine, which is produced by our research center “Vector”. This vaccine is called EpiVacCorona, and three thousand volunteers at eight medical centers in five constituent entities of the Russian Federation are already receiving vaccinations”, – she said during a meeting of Russian Prime Minister Mikhail Mishustin with vaccine manufacturers.

Comments:

comments powered by HyperComments